Loading...
8 Australia Autoinflammatory Disorders Reports
Country Covered: Australia
Study Period: 2019 - 2029
Major Players: Novartis AG, AbbVie Inc., Aciont Inc., Amgen, Tarsier Pharma Ltd
Country Covered: Australia
Study Period: 2019 - 2029
Major Players: Pfizer Inc, Mayne Pharma, Bristol‑Myers Squibb Company, Viatris, Perrigo Company plc
Country Covered: Australia
Study Period: 2019 - 2029
Major Players: Mallinckrodt Pharmaceuticals, Novartis AG, Teijin Pharmaceutical Limited, AbbVie (Allergan PLC), AdvaCare Pharma
Country Covered: Australia
Study Period: 2019 - 2029
Major Players: Shapecrunch Technology Pvt Ltd, Scholl’s Wellness Co., Ottobock, Algeo Limited, Bauerfeind
Country Covered: Australia
Study Period: 2019 - 2029
Major Players: Olympus Corporation, Medtronic plc, Cipla Inc., Dr. Reddy’s Laboratories Ltd., Stryker Corporation
Country Covered: Australia
Study Period: 2019 - 2029
Major Players: Pfizer Inc., Merck & Co., Inc , Baxter International Inc., Abbott Laboratories, B. Braun SE
Country Covered: Australia
Study Period: 2019 - 2029
Major Players: Bausch Health Inc. , AbbVie Inc. , Eyegate Pharmaceuticals, Inc., Clearside Biomedical inc., EyePoint Pharmaceuticals
Country Covered: Australia
Study Period: 2019 - 2029
Major Players: Bristol-Myers Squibb Company , AbbVie Inc., Takeda Pharmaceutical Company Limited , Johnson & Johnson Services Inc. (Janssen Biotech, Inc.) , Bausch Health Companies Inc. (Salix Pharmaceuticals)